Regencell Bioscience (RGC) stock drops 20% in Nasdaq trade as volatility flares again
New York, Jan 13, 2026, 14:12 EST — Regular session Shares of Regencell Bioscience Holdings Limited dropped over 20% on Tuesday, continuing a volatile streak that has kept the Nasdaq-listed microcap in the spotlight on momentum trackers. The decline is significant because the stock has proven it can swing sharply with little notice, a pattern that can catch late buyers off guard and trigger rapid sell-offs when liquidity dries up. The spotlight returns to what usually moves this stock daily: price action and positioning, rather than a steady stream of news. Investors are asking less “what changed” and more “how